Neurovascular/interventional neurological devices are devices that include coils, stents, thrombectomy devices, and other devices used to treat neurovascular diseases such as cerebral aneurysms and neurovascular thrombectomies. Thrombectomies, suction devices, and aspiration devices are used to remove blood clots from the arteries and veins of the brain, which can also cause strokes. Neurovascular devices are used to treat disorders associated with blood vessels that carry oxygenated blood to brain areas.
Market Dynamics
Increasing organic growth strategies such as product approvals by regulatory authorities are expected to drive the market growth over the forecast period. For instance, in July 2020, Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, announced that it has received Conformité Européenne (CE) Mark approval for its state-of-the-art CerusEndo MC 021 microcatheter, designed to allow physicians to access tortuous neurovasculature and deliver therapeutic devices to intended target. The CerusEndo MC 021 microcatheter is available in multiple distal flexible profiles and offers superior proximal support, which translates to enhanced deliverability and responsiveness in physicians’ hands.
Increasing inorganic growth strategies, such as agreements, by key market players to expand their product portfolios is expected to drive the market growth over the forecast period. For instance, in August 2020, Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company announced a distribution agreement with AB Medica Deutschland Verwaltungs GmbH, a wholly-owned subsidiary of Balt, to provide AB Medica Deutschland Verwaltungs GmbH with the exclusive rights to market and sell the newly Conformité Européenne (CE) marked Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter devices in Germany.
Key features of the study:
- This report provides an in-depth analysis of the global neurovascular devices market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neurovascular devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Medtronic Plc, Koninklijke Philips N.V., Abbott, Johnson & Johnson Service Inc., Merit Medical Systems, Inc., Stryker, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, Cerus Endovascular Limited., ASAHI INTECC USA, INC., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., iVascular, LifeHealthcare, Veiva, and Nordson MEDICAL
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neurovascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurovascular devices market
Detailed Segmentation:
- Global Neurovascular Devices Market, By Device Type:
- Embolization Coils
- Platinum Coils
- Coated Platinum Coils
- Liquid Embolic Coils
- Neurovascular Stents
- Carotid Artery Stents
- Flow Diversion Stents
- Neurothrombectomy Devices
- Clot Retrievers, Aspiration
- Suction Devices
- Vascular Snares
- Embolic Protection Devices
- Distal Filter Devices
- Balloon Occlusion Devices
- Neurovascular Supporting Devices
- Microcatheters
- Microguidewire
- Global Neurovascular Devices Market, By Therapeutic Application:
- Cerebral Aneurysms
- Ischemic Stroke
- Cerebral Artery Stenosis
- Arteriovenous Malformations (AVMs)
- AV Fistulas
- Others
- Global Neurovascular Devices Market, By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Global Neurovascular Devices Market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Medtronic Plc
- Koninklijke Philips N.V.
- Abbott
- Johnson & Johnson Service Inc.
- Merit Medical Systems, Inc.
- Stryker
- Penumbra, Inc.
- Acandis GmbH & Co. KG
- MicroPort Scientific Corporation
- Terumo Corporation
- Cerus Endovascular Limited.
- ASAHI INTECC USA, INC.
- ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
- iVascular
- LifeHealthcare
- Veiva
- Nordson MEDICAL
